Blog

Good Distribution Practice (GDP) Training

October 23, 2017
by SeerPharma

Yusen Logistics Singapore Pte Ltd provides freight forwarding and solutions which range from stand-alone operations to control-tower managed global supply chains, combining expertise with unique technology capabilities and a global service network. Globally, Yusen Logistics have offices in 43 countries, with over 22,000 employees. Yusen Logistics’ Regional headquarters for South Asia and Oceania operates from Singapore.

Yusen Logistics have invested heavily over the past 20 years in developing specialist new services and resources in the global pharma, biotech and healthcare supply chain. Solutions range from the delivery of raw materials into the manufacturing process to delivery of finished drugs and equipment to in-market distributors, hospitals, pharmacies and surgeries.

To assist in Yusen’s foray in the pharmaceutical, biotech and healthcare sector - SeerPharma (Singapore) Pte Ltd partnered with Yusen Logistics (Singapore) Pte Ltd to successfully deliver a Good Distribution Practice training course for the Regional Contract Logistics team at one of Yusen’s
distribution centres in Malaysia.

The program was developed to support the team’s knowledge of Good Distribution Practice (GDP) in relation to Good  Manufacturing Practice (GMP). The Good Distribution Practices training output enhanced the team’s ability to respond to customer requirements.

The take home messages included:

  • How does GDP relate to GMP
  • Clarifying the key elements for GDP
  • How the controls appropriate for the storage, trade and distribution of materials impact the distribution of pharmaceutical products

“Great to have you on board for the GDP training and thank you for coming up to Kuala Lumpur (Malaysia)”

Richard Gibson, Head of Healthcare (Eastern Hemisphere), Yusen Logistics

Contact us should you wish to learn more about Good Distribution Practices (GDP) in the pharmaceutical/biotechnology industry.

This post comes from our October 2017 Journal.  You may also be interested in:

Click here to see all SeerPharma Journal content

Filed Under: GDP, Good Distribution Practice